COVID-19 Treatments: Remdesivir Antiviral Drug

A double-blinded, placebo-controlled, randomized clinical trial provides support for FDA approval of Remdesivir for treating COVID-19. The FDA has just approved a new antiviral drug, Remdesivir from Gilead Sciences, for treating COVID-19 patients needing acute care in a hospital. This treatment was available until now under an Emergency Use Authorization (EUA), but a full FDA approval will facilitate broader use.

Industry NewsNaveen AgarwalOctober 26, 2020covid-19 treatments, COVID-19, covid-19, coronavirus crisis, coronavirus pandemic, FDA, Remdesivir, antibody cocktailComment